Regencell Bioscience Holdings Ltd (NASDAQ: RGC) has experienced a decline in its stock price by -10.43 compared to its previous closing price of 14.09. However, the company has seen a gain of 207.06% in its stock price over the last five trading days. globenewswire.com reported 2025-02-10 that ROANOKE, Va., Feb. 10, 2025 (GLOBE NEWSWIRE) — RGC Resources, Inc. (Nasdaq: RGCO) announced consolidated Company earnings of $5,269,689, or $0.51 per share, for the first quarter ended December 31, 2024, compared to $5,019,992, or $0.50 per share, for the fiscal quarter ended December 31, 2023.
Is It Worth Investing in Regencell Bioscience Holdings Ltd (NASDAQ: RGC) Right Now?
Additionally, the 36-month beta value for RGC is -2.11. There are mixed opinions on the stock, with 7 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 rating it as “hold,” and 1 rating it as “sell.”
The public float for RGC is 1.46M and currently, short sellers hold a 0.27% ratio of that float. The average trading volume of RGC on March 17, 2025 was 412.55K shares.
RGC’s Market Performance
The stock of Regencell Bioscience Holdings Ltd (RGC) has seen a 207.06% increase in the past week, with a 237.43% rise in the past month, and a 128.62% gain in the past quarter. The volatility ratio for the week is 65.99%, and the volatility levels for the past 30 days are at 22.66% for RGC. The simple moving average for the last 20 days is 144.27% for RGC’s stock, with a simple moving average of 117.57% for the last 200 days.
RGC Trading at 167.71% from the 50-Day Moving Average
After a stumble in the market that brought RGC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.10% of loss for the given period.
Volatility was left at 22.66%, however, over the last 30 days, the volatility rate increased by 65.99%, as shares surge +252.51% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +161.83% upper at present.
During the last 5 trading sessions, RGC rose by +207.06%, which changed the moving average for the period of 200-days by +94.45% in comparison to the 20-day moving average, which settled at $5.17. In addition, Regencell Bioscience Holdings Ltd saw 155.47% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for RGC
The total capital return value is set at -0.29. Equity return is now at value -42.49, with -40.85 for asset returns.
Currently, EBITDA for the company is -3.62 million with net debt to EBITDA at 0.53. The liquidity ratio also appears to be rather interesting for investors as it stands at 41.92.
Conclusion
In conclusion, Regencell Bioscience Holdings Ltd (RGC) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
